work for reasons similar to those described above. Once more, after pressure from the patients, we reached agreement with the health authority and the community health councils to have two short visiting spells each day-one in the afternoon and one in the early evening. The precise times and duration depend on the ward concerned.
We agree that the patient's needs are paramount but not the exclusive consideration. One patient's wishes should not be inflicted on other sick patients in neighbouring beds. The caring professions have a duty to tend their patients, but if this is constantly hindered by the excessive and prolonged presence of visitors we have a duty to consider where the priority lies. BRIAN 
ALDERMAN
Arrowe Park Hospital, Upton, Wirral, Merseyside L49 SPE Case-control study of cutaneous malignant melanoma SIR,-The abstract of the paper by Drs Dallas R English and Bruce K Armstrong on identifying people at high risk of cutaneous malignant melanoma (7 May, p 1285) is misleading in stating that ". . time spent outdoors in summer from the age of 10 to 24 . .. provided good discrimination between patients [with malignant melanoma] and controls...." In fact table I, which shows odds ratios for variables independently predicting risk of cutaneous malignant melanoma, and a small section in the results state that increasing exposure to sunlight between the ages of 10 and 24 was associated with a decreasing incidence ofcutaneous malignant melanoma. It would therefore seem that increasing exposure to sunlight between the ages of 10 and 24 years has a protective effect on the development of cutaneous malignant melanoma. This is an interesting finding, particularly in view of the large amounts ofmoney currently spent by the Australian government on the "Slip, Slop Although it seems that a reduction in exposure to the sun by Australians may increase the incidence of melanoma, our study also showed that arrival in Australia after the age of 10 was a strong independent predictor of a reduced risk of melanoma. The prevalence of naevi, which was the strongest risk factor for melanoma, was also reduced in these migrants. As Diet and inequalities in health SIR,-Dr J E Cade and others (14 May, p 1359) shows that, contrary to established wisdom, the fat content of diet in middle age is not related to the death rate from ischaemic heart disease. In fact, if the data from the three towns studied were taken in isolation they would suggest that a high fat diet conferred some protection. The incidence of ischaemic heart disease in the towns studied rises the further north the town is located, and this supports the suggestion that environmental cold stress may play an important part in explaining the geographical differences in the distribution of ischaemic heart disease, since the degree of cold stress is dependent on absolute temperature, air movement, and dampness. ' Although the social class distribution was similar in the three towns, the socioeconomic indices were worse in the two northern towns. Social class is usually closely related to socioeconomic indices, and the lower the social class the more likely it is that people are living in cold, damp housing. Low income, more common in the lower social classes, means that house repairs may have to be neglected, clothing may be of inferior quality and quantity, and energy intake may be marginal. Lower social class is also associated with smaller houses, poor insulation, and a higher number of people in each room. These factors increase the risk of damp.' 2 The lower the social class, or the worse the socioeconomic indices, the greater the potential for exposure to cold stress, a relation which matches the known gradation of incidence of ischaemic heart disease through the social classes.34 One of the physiological responses to exposure to cold stress is a rise in the circulating concentrations of catecholamines,' and it has been suggested that these play a part in the aetiology of ischaemic heart disease.' It seems probable that cold stress acts through catecholamines, and a paper is being prepared which reviews the evidence for the role of cold stress in the aetiologv of ischaemic heart disease.
F A patient with sepsis secondary to AIDS had had previous adverse drug reactions. After receiving treatment with a new antimicrobial agent he noticed a rash and was readmitted to hospital with a condition resembling toxic epidermal necrolysis, to which he eventually succumbed. His illness was consistent with other reports of drug induced toxic epidermal necrolysis. Literature searches and information from the manufacturer showed no reports of reactions of this type with this drug. The inpatient chart was used to prepare a report for publication. As a final check the outpatient chart was obtained, and, unlike the inpatient chart, this record indicated that he had previously undergone a skin biopsy, whose result had been suggestive of erythema multiforme. We reevaluated the cause and effect relation of this adverse drug reaction and did not submit it for publication.
Like most adverse drug reaction reports ours concerned a patient in hospital.S Presumably many such reports relied solely on the inpatient record. In large teaching hospitals the patient may not be known to the team, and the history obtained from an abbreviated summary may be incomplete. Therefore reports prepared from only inpatient documents may lack relevant information. New drugs are often held responsible for otherwise unexplained clinical situations. Using only inpatient documents the published algorithms classify our case as a possible adverse drug reaction.' 2 Consequently, even objectively identified reports which include the requisite information4 may be incorrect. We concur with previously proposed requirements and additionally recommend that the patient's outpatient record should be consulted before the clinician concludes that an adverse drug reaction has occurred. 
Neutropenia following intravenous immunoglobulin
Drs P A VEYS, M G MACEY, C M OWENS, and A C NEWLAND (Department of Haematology, The London Hospital, London El 1BB) write: Drs R V Majer and P J Green reported the occurrence of temporary neutropenia in two patients receiving high dose intravenous immunoglobulin (30 April, p 1262) and concluded that this was a side effect that had not been reported previously. This is, however, a frequently observed although not widely reported effect.
We studied the neutrophil counts in 48 patients with idiopathic thrombocytopenic purpura who received intravenous immunoglobulin. There was a significant decrease (p<0001) from the count before treatment (mean 6Ox109/l) to that on days three and four (mean 3 Ox 109/l). There was a correlation between the decrease in neutrophil count and the increase in platelet count (p<001). The neutropenic period was brief, and counts returned to normal by day seven.
We studied six patients in detail. Five developed a significant but brief reduction in absolute neutrophil count during the infusion of immunoglobulin. Using flow cytometric studies of patient and donor leucocytes we confirmed specific binding of intravenous immunoglobulin to the neutrophil surface in vivo and in vitro.' Ultracentrifugation of the immunoglobulin to remove IgG aggregates before testing reduced the amount of IgG binding in vitro. The expression of neutrophil FcR III, a receptor which has a low affinity for monomeric IgG,' varied in a reciprocal fashion to the amount of bound IgG, suggesting that the small amount of IgG aggregates remaining in the intravenous immunoglobulin is responsible for the specific binding of IgG to the FcR III.
Clarkson et al reported a temporary platelet increment accompanied by a profound neutropenia in a patient with refractory idiopathic thrombocytopenic purpura after a monoclonal antibody to the FcR III was given.3 This also suggests that the neutropenia might be mediated through this receptor.
In one patient with longstanding idiopathic thrombocytopenic purpura who had a temporary platelet response to intravenous immunoglobulin there was a reduction in the absolute neutrophil count from 5 1 to 2-2 x 10/1 after the first two infusions. The count remained low for about 10 days (figure). The neutrophil FcR III expression was reduced in the same manner, returning to normal only with the cessation of the platelet response.
We suggest that the reduction in neutrophil count after intravenous immunoglobulin is not just a side effect. Indeed, a reduction in neutrophil phagocytic capability and mononuclear phagocyte blockade by neutrophils coated with IgG might contribute to the platelet increment in some patients with idiopathic thrombocytopenic purpura. None of our 54 patients suffered any infective complications during the neutropenic episodes, and we think that, while fairly common, the neutropenia after intravenous immunoglobulin is of little clinical concern. Vaccination against influenza is recommended for patients at increased risk of lower respiratory tract infections. The safety ofthe vaccine is well established, the usual side effects being a mild serum sickness with fever, malaise, and myalgia.' A 77 year old man developed malaise, diarrhoea, and arthralgia 10 days after receiving 0-5 ml of inactivated influenza vaccine surface antigen (Influvac). On admission his blood pressure was 95/60 mm Hg, and ankle and sacral oedema were present. His abdomen was distended, and bowel sounds were reduced. A purpuric rash was present over his buttocks and legs, and the knee and ankle joints were tender.
The haemoglobin concentration was 147 g/l, the white cell count 13-6x 109/l (92% neutrophils), the platelet count 407 x 109/l, and the erythrocyte sedimentation rate 30 mm in the first hour. Plasma urea and creatinine concentrations were raised at 21-1 mmol/l and 204 fmol/l respectively, and the albumin concentration was reduced at 30 g/l. A midstream urine specimen contained SOx 109 red cells/I and showed pronounced proteinuria.
After admission the patient developed haematemesis and melaena. Renal function deteriorated further, and percutaneous renal biopsy was performed. All of the glomeruli were abnormal with an increase in mesangial cells and matrix and patchy deposition of IgA, IgM, and C2 in relation to glomerular capillaries. The tubules and interstitial tissue were unremarkable. Oral prednisolone 60 mg daily was started. Renal function improved and the rash, arthralgia, and gastrointestinal disturbance resolved. Four week later the plasma creatinine concentration was 137 gmol/l, and there was no blood or protein on analysis of urine.
Immunological investigations were performed on serum collected 10 days afteradmission. No antibodies to influenza A or B, cytomegalovirus, Mycoplasma pneumoniae, chlamydia, or Q fever were detectable by complement fixation tests, but antibodies to Influvac (IgG 1/12800, IgA 1/400) were detected by enzyme linked immunosorbent assay (ELISA). No antibodies to ovalbumin were detected.
Henoch-Schonlein purpura is commonly preceded by symptoms of an upper respiratory tract infection, and relapses may be related to further infections. Preexisting Henoch-Schonlein purpura may be exacerbated by influenza vaccination2 but we are unaware of any report of Henoch-Schonlein purpura caused by the vaccination. Hypersensitivity reactions to influenza vaccine are thought to relate to allergy to vaccine components such as egg protein. It is possible, however, that immune complexes may form as a result of interaction between influenza vaccine antigens and native antibodies, initiating a vasculitic syndrome.3
